Literature DB >> 26333527

Levels of cytokines in broncho-alveolar lavage fluid, but not in plasma, are associated with levels of markers of lipid peroxidation in breath of ventilated ICU patients.

Margit Boshuizen1, Jan Hendrik Leopold, Tetyana Zakharkina, Hugo H Knobel, Hans Weda, Tamara M E Nijsen, Teunis J Vink, Peter J Sterk, Marcus J Schultz, Lieuwe D J Bos.   

Abstract

Alkanes and alkenes in the breath are produced through fatty acid peroxidation, which is initialized by reactive oxygen species. Inflammation is an important cause and effect of reactive oxygen species. We aimed to evaluate the association between fatty acid peroxidation products and inflammation of the alveolar and systemic compartment in ventilated intensive care unit (ICU) patients.Volatile organic compounds were measured by gas chromatography and mass spectrometry in the breath of newly ventilated ICU patients within 24 h after ICU admission. Cytokines were measured in non-directed bronchial lavage fluid (NBL) and plasma by cytometric bead array. Correlation coefficients were calculated and presented in heatmaps.93 patients were included. Peroxidation products in exhaled breath were not associated with markers of inflammation in plasma, but were correlated with those in NBL. IL-6, IL-8, IL-1β and TNF-α concentration in NBL showed inverse correlation coefficients with the peroxidation products of fatty acids. Furthermore, NBL IL-10, IL-13, GM-CSF and IFNγ demonstrated positive associations with breath alkanes and alkenes. Correlation coefficients for NBL cytokines were high regarding peroxidation products of n-6, n-7 and particularly in n-9 fatty acids.Levels of lipid peroxidation products in the breath of ventilated ICU patients are associated with levels of inflammatory markers in NBL, but not in plasma. Alkanes and alkenes in breath seems to be associated with an anti-inflammatory, rather than a pro-inflammatory state in the alveoli.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26333527     DOI: 10.1088/1752-7155/9/3/036010

Source DB:  PubMed          Journal:  J Breath Res        ISSN: 1752-7155            Impact factor:   3.262


  6 in total

1.  Linking physiological parameters to perturbations in the human exposome: Environmental exposures modify blood pressure and lung function via inflammatory cytokine pathway.

Authors:  Matthew A Stiegel; Joachim D Pleil; Jon R Sobus; Tina Stevens; Michael C Madden
Journal:  J Toxicol Environ Health A       Date:  2017-07-11

Review 2.  Evolution of clinical and environmental health applications of exhaled breath research: Review of methods and instrumentation for gas-phase, condensate, and aerosols.

Authors:  M Ariel Geer Wallace; Joachim D Pleil
Journal:  Anal Chim Acta       Date:  2018-02-09       Impact factor: 6.558

3.  Specific Metabolome Profile of Exhaled Breath Condensate in Patients with Shock and Respiratory Failure: A Pilot Study.

Authors:  Brice Fermier; Hélène Blasco; Emmanuel Godat; Cinzia Bocca; Joseph Moënne-Loccoz; Patrick Emond; Christian R Andres; Marc Laffon; Martine Ferrandière
Journal:  Metabolites       Date:  2016-09-01

Review 4.  Exhaled Aldehydes as Biomarkers for Lung Diseases: A Narrative Review.

Authors:  Maximilian Alexander Floss; Tobias Fink; Felix Maurer; Thomas Volk; Sascha Kreuer; Lukas Martin Müller-Wirtz
Journal:  Molecules       Date:  2022-08-17       Impact factor: 4.927

5.  Ethylene, an early marker of systemic inflammation in humans.

Authors:  Laurent M Paardekooper; Geert van den Bogaart; Matthijs Kox; Ilse Dingjan; Anne H Neerincx; Maura B Bendix; Martin Ter Beest; Frans J M Harren; Terence Risby; Peter Pickkers; Nandor Marczin; Simona M Cristescu
Journal:  Sci Rep       Date:  2017-07-31       Impact factor: 4.379

6.  Increased mortality in elderly patients with acute respiratory distress syndrome is not explained by host response.

Authors:  Laura R A Schouten; Lieuwe D J Bos; A Serpa Neto; Lonneke A van Vught; Maryse A Wiewel; Arie J Hoogendijk; Marc J M Bonten; Olaf L Cremer; Janneke Horn; Tom van der Poll; Marcus J Schultz; Roelie M Wösten-van Asperen
Journal:  Intensive Care Med Exp       Date:  2019-10-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.